Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Lena Al-Harthi and Alan Landay.
Connection Strength

3.271
  1. Immunophenotypic alterations in acute and early HIV infection. Clin Immunol. 2007 Dec; 125(3):299-308.
    View in: PubMed
    Score: 0.304
  2. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Med. 2004 Jan; 5(1):55-65.
    View in: PubMed
    Score: 0.234
  3. Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategies. J Hematother Stem Cell Res. 2002 Oct; 11(5):777-86.
    View in: PubMed
    Score: 0.215
  4. Trophoblasts are productively infected by CD4-independent isolate of HIV type 1. AIDS Res Hum Retroviruses. 2002 Jan 01; 18(1):13-7.
    View in: PubMed
    Score: 0.204
  5. HIV in the female genital tract: viral shedding and mucosal immunity. Clin Obstet Gynecol. 2001 Jun; 44(2):144-53.
    View in: PubMed
    Score: 0.196
  6. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res. 2000 Aug; 20(8):719-24.
    View in: PubMed
    Score: 0.185
  7. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS. 2000 May 05; 14(7):761-70.
    View in: PubMed
    Score: 0.182
  8. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA). J Immunol Methods. 2000 Apr 03; 237(1-2):187-97.
    View in: PubMed
    Score: 0.181
  9. Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production. J Clin Immunol. 1998 Mar; 18(2):124-31.
    View in: PubMed
    Score: 0.156
  10. Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor. J Infect Dis. 1997 Nov; 176(5):1175-9.
    View in: PubMed
    Score: 0.153
  11. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus. J Infect Dis. 2010 Mar 15; 201(6):823-34.
    View in: PubMed
    Score: 0.090
  12. CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis. 2008 May 15; 197(10):1402-7.
    View in: PubMed
    Score: 0.079
  13. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology. 2007 Apr; 120(4):526-35.
    View in: PubMed
    Score: 0.073
  14. HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):269-77.
    View in: PubMed
    Score: 0.072
  15. Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway. Virology. 2006 Jul 05; 350(2):443-52.
    View in: PubMed
    Score: 0.068
  16. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis. 2006 May 01; 193(9):1202-10.
    View in: PubMed
    Score: 0.068
  17. Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells. Immunology. 2005 Mar; 114(3):322-35.
    View in: PubMed
    Score: 0.063
  18. Dynamics of cytokine expression in HIV productively infected primary CD4+ T cells. Blood. 2004 Jun 15; 103(12):4581-7.
    View in: PubMed
    Score: 0.059
  19. CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood. 2003 Sep 15; 102(6):2156-64.
    View in: PubMed
    Score: 0.056
  20. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology. 2003 Jan; 108(1):3-9.
    View in: PubMed
    Score: 0.055
  21. Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood. 2002 May 01; 99(9):3310-8.
    View in: PubMed
    Score: 0.052
  22. Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens. J Acquir Immune Defic Syndr. 2002 Apr 15; 29(5):544-5.
    View in: PubMed
    Score: 0.052
  23. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals. AIDS. 2001 Sep 28; 15(14):1757-64.
    View in: PubMed
    Score: 0.050
  24. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS. 2001 Aug 17; 15(12):1535-43.
    View in: PubMed
    Score: 0.050
  25. Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology. 2001 Jul; 103(3):270-80.
    View in: PubMed
    Score: 0.049
  26. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and na?ve phenotypes. Clin Immunol. 2000 Nov; 97(2):95-101.
    View in: PubMed
    Score: 0.047
  27. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr. 1999 Jul 01; 21(3):194-202.
    View in: PubMed
    Score: 0.043
  28. A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis. 1998 Nov; 178(5):1343-51.
    View in: PubMed
    Score: 0.041
  29. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS. 1997 Sep; 11(11):1319-26.
    View in: PubMed
    Score: 0.038
  30. Immunological effects of antiretroviral and immune therapies for HIV. AIDS. 1997; 11 Suppl A:S149-55.
    View in: PubMed
    Score: 0.036
  31. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):172-80.
    View in: PubMed
    Score: 0.034
  32. Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels. J Infect Dis. 2007 Mar 01; 195(5):734-8.
    View in: PubMed
    Score: 0.018
  33. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J Immunol. 2006 Jul 15; 177(2):1028-39.
    View in: PubMed
    Score: 0.017
  34. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection. J Infect Dis. 2003 Dec 15; 188(12):1804-14.
    View in: PubMed
    Score: 0.015
  35. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr. 2003 Jun 01; 33(2):175-83.
    View in: PubMed
    Score: 0.014
  36. Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load. AIDS. 2002 Nov 08; 16(16):2119-27.
    View in: PubMed
    Score: 0.014
  37. Rationale for immune-based therapies for HIV-1 infection. J Lab Clin Med. 1998 Mar; 131(3):197-206.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.